BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16503502)

  • 1. Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.
    Leather H; Boyette RM; Tian L; Wingard JR
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):325-34. PubMed ID: 16503502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
    Timmers GJ; Kessels LW; Wilhelm AJ; Veldkamp AI; Bosch TM; Beijnen JH; Huijgens PC
    Ther Drug Monit; 2008 Jun; 30(3):301-5. PubMed ID: 18520601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Int J Hematol; 2009 Jul; 90(1):103-107. PubMed ID: 19472033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
    Nara M; Takahashi N; Miura M; Niioka T; Kagaya H; Fujishima N; Saitoh H; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1321-9. PubMed ID: 23354810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
    Osowski CL; Dix SP; Lin LS; Mullins RE; Geller RB; Wingard JR
    Transplantation; 1996 Apr; 61(8):1268-72. PubMed ID: 8610430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.
    Trifilio SM; Scheetz MH; Pi J; Mehta J
    Bone Marrow Transplant; 2010 Aug; 45(8):1352-6. PubMed ID: 19966844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
    Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
    Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
    Nara M; Takahashi N; Miura M; Saitoh H; Kagaya H; Sawada K
    Am J Hematol; 2010 Aug; 85(8):634-5. PubMed ID: 20568249
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.
    Leather HL
    Bone Marrow Transplant; 2004 Jan; 33(2):137-52. PubMed ID: 14676788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin does not influence the concentration of tacrolimus in patients after allogeneic hematopoietic stem cell transplantation.
    Fukuoka N; Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Ishida T; Tanaka T
    Transplant Proc; 2010 Sep; 42(7):2725-30. PubMed ID: 20832577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.
    Onizuka M; Kunii N; Toyosaki M; Machida S; Ohgiya D; Ogawa Y; Kawada H; Inoko H; Ando K
    Bone Marrow Transplant; 2011 Aug; 46(8):1113-7. PubMed ID: 21102498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
    Brandhorst G; Tenderich G; Zittermann A; Oezpeker C; Koerfer R; Oellerich M; Armstrong VW
    Ther Drug Monit; 2008 Feb; 30(1):113-6. PubMed ID: 18223473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
    Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
    Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.